Although our data suggest that the level of GFAP degradation products might correlate with the disease severity, because increased levels of GFAP fragments were found mainly in younger AxD patients, testing of such a hypothesis awaits the availability of more human neuropathological materials from AxD patients. Here, GFAP is linked to Alexander disease.